학술논문
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC
Document Type
Article
Author
Source
In Journal of Thoracic Oncology June 2023 18(6):718-730
Subject
Language
ISSN
1556-0864